Filter

Refine by collections

  • Hormones and Cancer (7)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 7 of 7 items for :

  • "rare diseases" x
  • Hormones and Cancer x
Clear All
E K White Division of Endocrinology and Centre for Endocrine Tumors, Department of Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by E K White in
Google Scholar
PubMed Close
,
I V Wagner Department of Endocrinology & Metabolism, Amsterdam University Medical Centre, Amsterdam, The Netherlands

Search for other papers by I V Wagner in
Google Scholar
PubMed Close
,
C van Beuzekom Division of Endocrinology and Centre for Endocrine Tumors, Department of Medicine, Leiden University Medical Centre, Leiden, The Netherlands
Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by C van Beuzekom in
Google Scholar
PubMed Close
,
V Iotova Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Lübeck, Lübeck, Germany

Search for other papers by V Iotova in
Google Scholar
PubMed Close
,
S F Ahmed Office for Rare Conditions, University of Glasgow, Glasgow, UK
Department of Paediatrics, UMHAT ‘Sveta Marina’ Varna, Medical University of Varna, Varna, Bulgaria

Search for other papers by S F Ahmed in
Google Scholar
PubMed Close
,
O Hiort Department of Endocrinology & Metabolism, Amsterdam University Medical Centre, Amsterdam, The Netherlands

Search for other papers by O Hiort in
Google Scholar
PubMed Close
, and
A M Pereira Faculty of Medicine Division 2, Internal Medicine Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by A M Pereira in
Google Scholar
PubMed Close

pandemic might have influenced the CPMS usage. On the one hand, clinicians were facing more work in hospitals with outpatients and COVID-19 patients and understandably did not have sufficient time to spend on individual patient cases with rare diseases

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0281
Volume/Issue:
Volume 11: Issue 11
Open access
Hélène Singeisen Department of Internal Medicine, Endocrinology, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Hélène Singeisen in
Google Scholar
PubMed Close
,
Mariko Melanie Renzulli Institute of Radiology, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed Close
,
Vojtech Pavlicek Department of Internal Medicine, Endocrinology, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed Close
,
Pascal Probst Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Pascal Probst in
Google Scholar
PubMed Close
,
Fabian Hauswirth Department of Surgery, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed Close
,
Markus K Muller Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Markus K Muller in
Google Scholar
PubMed Close
,
Magdalene Adamczyk Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed Close
,
Achim Weber Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Search for other papers by Achim Weber in
Google Scholar
PubMed Close
,
Reto Martin Kaderli Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland

Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed Close
, and
Pietro Renzulli Department of Surgery, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Pietro Renzulli in
Google Scholar
PubMed Close

the underlying genetic variants. Conclusions MEN4, first described in 2006, is a very rare disease with only a few dozen cases reported in the literature. The underlying genetic alternations and the phenotypic manifestations are still poorly

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0411
Volume/Issue:
Volume 12: Issue 2
Open access
Carole Morin Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Carole Morin in
Google Scholar
PubMed Close
,
Keo-Morakort Benedetto Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Keo-Morakort Benedetto in
Google Scholar
PubMed Close
,
Agathe Deville Hospices Civils de Lyon, Hôpital Louis Pradel, Médecine Nucléaire, Bron, France
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France

Search for other papers by Agathe Deville in
Google Scholar
PubMed Close
,
Laurent Milot Hospices Civils de Lyon, Hôpital Edouard Herriot, Radiologie, Lyon Cedex 03, France
University of Lyon, Université Lyon 1, France

Search for other papers by Laurent Milot in
Google Scholar
PubMed Close
,
Aurélie Theillaumas Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Aurélie Theillaumas in
Google Scholar
PubMed Close
,
Valérie Hervieu Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France

Search for other papers by Valérie Hervieu in
Google Scholar
PubMed Close
,
Mathieu Pioche University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, France

Search for other papers by Mathieu Pioche in
Google Scholar
PubMed Close
,
Gilles Poncet Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France

Search for other papers by Gilles Poncet in
Google Scholar
PubMed Close
,
Julien Forestier Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Julien Forestier in
Google Scholar
PubMed Close
,
Laurent François Hospices Civils de Lyon, Hôpital Louis Pradel, Exploration Fonctionnelle, Bron Cedex, France

Search for other papers by Laurent François in
Google Scholar
PubMed Close
,
Francoise Borson-Chazot University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, France

Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed Close
,
Mustapha Adham University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France

Search for other papers by Mustapha Adham in
Google Scholar
PubMed Close
,
Catherine Lombard-Bohas Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed Close
, and
Thomas Walter Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France

Search for other papers by Thomas Walter in
Google Scholar
PubMed Close

Introduction Neuroendocrine neoplasm (NEN) is a rare disease, though its incidence is rising ( 1 , 2 ). NENs are heterogeneous diseases regarding the number of primary origins, clinical presentation, staging, grading, and prognosis. Their

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0097
Volume/Issue:
Volume 11: Issue 6
Open access
Malgorzata Fuksiewicz Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Malgorzata Fuksiewicz in
Google Scholar
PubMed Close
,
Maria Kowalska Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Maria Kowalska in
Google Scholar
PubMed Close
,
Agnieszka Kolasinska-Cwikla Department of Oncology and Radiotherapy, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Agnieszka Kolasinska-Cwikla in
Google Scholar
PubMed Close
, and
Beata Kotowicz Laboratory of Tumor Markers, Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Search for other papers by Beata Kotowicz in
Google Scholar
PubMed Close

) ( 13 ). Neuroendocrine tumours are a heterogeneous group of tumours originating from cells of the diffuse neuroendocrine system. These tumours are classified as rare diseases, although a steady increase in incidence has been observed. The analysis of

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0647
Volume/Issue:
Volume 11: Issue 9
Open access
Xiaoya Zheng Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed Close
,
Shanshan Yu Pathology Department, Chongqing Medical University, Chongqing, China

Search for other papers by Shanshan Yu in
Google Scholar
PubMed Close
,
Jian Long Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Jian Long in
Google Scholar
PubMed Close
,
Qiang Wei Prevention of Disease Department, Chongqing Jiulongpo District Hospital of Traditional Chinese Medicine, Chongqing, China

Search for other papers by Qiang Wei in
Google Scholar
PubMed Close
,
Liping Liu Department of Ultrasound, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Liping Liu in
Google Scholar
PubMed Close
,
Chun Liu Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Chun Liu in
Google Scholar
PubMed Close
, and
Wei Ren Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Wei Ren in
Google Scholar
PubMed Close

better prognosis ( 13 ). There are some limitations to this study. First, we had a small population size for PTL and DSVPTC because both were rare diseases, and it was difficult to obtain many cases for the analysis. Secondly, we only retrospectively

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0364
Volume/Issue:
Volume 11: Issue 1
Open access
Anna Gorbacheva Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Anna Gorbacheva in
Google Scholar
PubMed Close
,
Anna Eremkina Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Anna Eremkina in
Google Scholar
PubMed Close
,
Daria Goliusova Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Daria Goliusova in
Google Scholar
PubMed Close
,
Julia Krupinova Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Julia Krupinova in
Google Scholar
PubMed Close
, and
Natalia Mokrysheva Endocrinology Research Center, Moscow, Russian Federation

Search for other papers by Natalia Mokrysheva in
Google Scholar
PubMed Close

endocrine tumors: clinical manifestations and genetic bases . Orphanet Journal of Rare Diseases 2020 15 102. ( https://doi.org/10.1186/s13023-020-01380-1 ) 23 Khan AA Hanley DA Rizzoli R Bollerslev J Young JEM Rejnmark L Thakker R D

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-21-0494
Volume/Issue:
Volume 11: Issue 3
Open access
Ruth Percik Institute of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel

Search for other papers by Ruth Percik in
Google Scholar
PubMed Close
,
Sherwin Criseno Department of Endocrinology, University Hospital Birmingham, Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Safwaan Adam Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Safwaan Adam in
Google Scholar
PubMed Close
,
Kate Young Royal Marsden Hospital, London, UK

Search for other papers by Kate Young in
Google Scholar
PubMed Close
, and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK
Royal Marsden Hospital, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed Close

adrenocorticotropic hormone deficiency: from a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors . Autoimmunity Reviews 2020 19 102454 . https://doi.org/10.1016/j.autrev.2019.102454 . 29 Faje AT Lawrence D Flaherty

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0513
Volume/Issue:
Volume 12: Issue 5
Open access